200 related articles for article (PubMed ID: 3165528)
1. [Carcinoembryonic antigen, Ca 19-9 and Ca 125 antigen levels in the sera of patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Pol Tyg Lek; 1988 Feb; 43(5):136-9. PubMed ID: 3165528
[No Abstract] [Full Text] [Related]
2. The tumor markers CEA, TPA and CA 19-9 in gastric cancer.
Putzki H; Reichert B; Jablonski M; Heymann H
Dtsch Z Verdau Stoffwechselkr; 1988; 48(3-4):145-8. PubMed ID: 3234297
[TBL] [Abstract][Full Text] [Related]
3. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
4. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative determination of CEA and GICA in gastric neoplasms].
Sanlorenzo M; Caldarola F; Vigezzi P; Rocca N; Pecchio F
Minerva Med; 1989 Mar; 80(3):255-9. PubMed ID: 2717045
[TBL] [Abstract][Full Text] [Related]
6. [The comparative study of biological behavior between primary lesion and metastatic lymph node of gastric cancer--immunohistochemical study of CEA and CA 19-9].
Takahashi Y; Minami S; Mai M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2233-4. PubMed ID: 3459399
[No Abstract] [Full Text] [Related]
7. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER].
Buda F; Aragona P; Giani G; Sisto R; Di Nardo G; Binotto F; Gangemi P; De Zerbi T; Gentile G; Papadia A
G Ital Oncol; 1989; 9(2-3):67-72. PubMed ID: 2767730
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers in gastrointestinal cancer and its clinical significance].
Taguchi T; Ota J; Sumida S; Rii M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
[TBL] [Abstract][Full Text] [Related]
9. [Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4].
Sagredo E; Soriano A; Vivanco FJ; Ruibal A
Rev Clin Esp; 1989 Apr; 184(6):336-7. PubMed ID: 2756226
[No Abstract] [Full Text] [Related]
10. [Tumor markers in the upper intestinal tract--stomach and pancreas].
Pointner R; Conrad F; Schwab G
Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485
[TBL] [Abstract][Full Text] [Related]
11. Investigation of serum tumor markers in the diagnosis of gastric cancer.
Fan B; Xiong B
Hepatogastroenterology; 2011; 58(105):239-45. PubMed ID: 21510322
[TBL] [Abstract][Full Text] [Related]
12. [Carcinoma of the ovary: reliability of its markers].
Moggian G; Gunelli R; Magrone F; Canali P; Spadazzi AP; Pini PL
Minerva Ginecol; 1988 Jan; 40(1):9-13. PubMed ID: 3163780
[No Abstract] [Full Text] [Related]
13. [Tumor markers in the diagnosis of tumors in the subhepatic area].
Dufek V; Petrtýl J; Klener P; Chmel J
Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
[TBL] [Abstract][Full Text] [Related]
14. Levels of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) in sera and pancreatic juice in the diagnosis of pancreatic cancer.
Lin JT; Wang TH; Chen DS; Sung JL
Taiwan Yi Xue Hui Za Zhi; 1987 Aug; 86(8):823-8. PubMed ID: 3479516
[No Abstract] [Full Text] [Related]
15. [The determination of the concentration of the carcinoembryonic and meconial antigens in the gastric juice of patients with stomach pathology].
Krylov IuV; Pugachev KK; Zhavoronok SV; Shimbireva IB; Perkovskiĭ GA
Vopr Onkol; 1992; 38(2):188-95. PubMed ID: 1300705
[TBL] [Abstract][Full Text] [Related]
16. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
Safi F; Rappenecker B; Roscher R; Beger HG
Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
[No Abstract] [Full Text] [Related]
17. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
Spila A; Roselli M; Cosimelli M; Ferroni P; Cavaliere F; Arcuri R; Tedesco M; Carlini S; D'Alessandro R; Perri P; Casciani CU; Greiner JW; Schlom J; Guadagni F
Anticancer Res; 1996; 16(4B):2241-7. PubMed ID: 8694550
[TBL] [Abstract][Full Text] [Related]
19. [Clinical utility of tumor markers in gastric and colon cancer].
Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
[TBL] [Abstract][Full Text] [Related]
20. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]